Skip to main content

Cobimetinib plus vemurafenib (C plus V) in patients (Pts) with colorectal cancer (CRC) with BRAFV600E mutations: Results from the TAPUR Study

Publication ,  Conference
Klute, K; Garrett-Mayer, E; Halabi, S; Mangat, PK; Nazemzadeh, R; Yost, KJ; Butler, NL; Perla, V; Schilsky, RL
Published in: JOURNAL OF CLINICAL ONCOLOGY
2020

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2020

Volume

38

Issue

4

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Klute, K., Garrett-Mayer, E., Halabi, S., Mangat, P. K., Nazemzadeh, R., Yost, K. J., … Schilsky, R. L. (2020). Cobimetinib plus vemurafenib (C plus V) in patients (Pts) with colorectal cancer (CRC) with BRAF V600E mutations: Results from the TAPUR Study. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38).
Klute, Kelsey, Elizabeth Garrett-Mayer, Susan Halabi, Pam K. Mangat, Reza Nazemzadeh, Kathleen J. Yost, Nicole L. Butler, Venu Perla, and Richard L. Schilsky. “Cobimetinib plus vemurafenib (C plus V) in patients (Pts) with colorectal cancer (CRC) with BRAF V600E mutations: Results from the TAPUR Study.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.
Klute K, Garrett-Mayer E, Halabi S, Mangat PK, Nazemzadeh R, Yost KJ, et al. Cobimetinib plus vemurafenib (C plus V) in patients (Pts) with colorectal cancer (CRC) with BRAF V600E mutations: Results from the TAPUR Study. In: JOURNAL OF CLINICAL ONCOLOGY. 2020.
Klute K, Garrett-Mayer E, Halabi S, Mangat PK, Nazemzadeh R, Yost KJ, Butler NL, Perla V, Schilsky RL. Cobimetinib plus vemurafenib (C plus V) in patients (Pts) with colorectal cancer (CRC) with BRAF V600E mutations: Results from the TAPUR Study. JOURNAL OF CLINICAL ONCOLOGY. 2020.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2020

Volume

38

Issue

4

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences